NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/05/2024
Back to search
Official data from USPTO
STIVAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
06/05/2024
Trademark type
Combined
Nice classes
10
Filing date
02/21/2013
Registration date
11/26/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/05/2024
Last transaction
06/05/2024
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Mauerbach, AT
Examiner
CORWIN, KEVIN SCOTT
Current location
Historical data usage
Mark description
The mark consists of the stylized orange wording "STIVAX" with a curved grey band passing beneath the wording and bending upward at its right end and terminating immediately after the "X" in "STIVAX".
Holders and representatives
Holders
Biegler GmbH
Biegler GmbH
Representatives
Michael J. Leonard Fox Rothschild LLP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical instruments and apparatusa neuro-stimulator employing electrical pulses emitted through needles selectively positioned in the body for treatment of chronic pain
Publications
History of USPTO decisions and trademark events.
43 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
06/05/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/04/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/04/2023
ES71
TEAS SECTION 71 RECEIVED
10/07/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/17/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11/26/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/22/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/22/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/22/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/01/2021
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
01/27/2020
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
01/27/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/23/2020
ES75
TEAS SECTION 71 & 15 RECEIVED
11/26/2019
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/26/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/23/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/07/2014
FIMP
FINAL DISPOSITION PROCESSED
05/07/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/26/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2013
GPNX
NOTIFICATION PROCESSED BY IB
09/16/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/10/2013
PUBO
PUBLISHED FOR OPPOSITION
09/10/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/28/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/28/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/21/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/02/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/29/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/29/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/29/2013
ALIE
ASSIGNED TO LIE
07/25/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/23/2013
RFNT
REFUSAL PROCESSED BY IB
07/01/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/07/2013
RFRR
REFUSAL PROCESSED BY MPU
06/07/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/07/2013
CNRT
NON-FINAL ACTION WRITTEN
06/06/2013
DOCK
ASSIGNED TO EXAMINER
06/06/2013
MAFR
APPLICATION FILING RECEIPT MAILED
04/06/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/02/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/28/2013
Continuous trademark protection
Get notified about every new filing that threatens STIVAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.